Identification of ErbB (EGFR, HER2) playing a role in tumour radioresistance has led to attempts to sensitize tumours by inhibiting receptor signalling13, 14, 15, 16, 17, 18, 19, 20. Here, ERBB2 is linked to neoplasm.